Search results for "Acute disease"

showing 10 items of 430 documents

Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia

2000

The t(10;11)(p12-p13;q14-q21) observed in a subset of patients with either acute lymphoblastic leukemia or acute myeloid leukemia has been shown to result in the fusion of AF10 on chromosome 10 with CALM (also named CLTH) on chromosome 11. AF10 was originally identified as a fusion partner of MLL in the t(10;11)(p12-p13;q23) observed in myeloid leukemia. CALM is a newly isolated gene, cloned as the fusion partner of AF10 in the monocytoid cell line, U937. In order to understand the relationship between MLL, AF10, CALM and the leukemic process, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction were used to study a series of nine leukemia patients with a t…

AdultMaleCancer ResearchMyeloidOncogene Proteins FusionChromosomal translocationBiologyImmunophenotypingImmunophenotypinghemic and lymphatic diseasesAcute lymphocytic leukemiamedicineHumansCloning MolecularChildneoplasmsIn Situ Hybridization FluorescenceDNA PrimersABLBase Sequencemedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionMyeloid leukemiaHematologyMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseVirologyLeukemiamedicine.anatomical_structureOncologyLeukemia MyeloidAcute DiseaseCancer researchFluorescence in situ hybridizationLeukemia
researchProduct

Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial

1994

Background. A single‐institution, prospective, randomized open trial was performed to compare ondansetron and granisetron in the prevention of chemotherapyrelated nausea and vomiting. The effect of antemetic drugs was analyzed indipendently for patients treated with highly emetogenic chemotherapy (Study 1), and those treated with moderately emetogenic regimens (Study 2). Methods. In Study 1. 182 patients treated with chemotherapeutic regimens containing high dose cisplatin (more than 70 mg/m2) were randomized to receive 24 mg of ondasentron intravenously (i. v.) or 3 mg of granisetron i. v. for the control of acute emesis. Patients treated with fractionated chemotherapy and those followed‐u…

AdultMaleCancer ResearchNauseaVomitingmedicine.medical_treatmentAntineoplastic AgentsGranisetronchemotherapyDrug Administration Schedulelaw.inventionOndansetronRandomized controlled triallawmedicineHumansgranisetronProspective StudiesProspective cohort studyAgedChemotherapybusiness.industryMiddle AgednauseamovitingOncologyondansetronAnesthesiaAcute DiseaseVomitingFemalemedicine.symptomCisplatinbusinessmedicine.drugChemotherapy-induced nausea and vomiting
researchProduct

Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study

2016

In the last decades, evaluation of clinically relevant thrombotic complications in patients with acute leukemia (AL) has been poorly investigated. The authors performed a multi-center study to evaluate the management of symptomatic venous thromboembolism (VTE) in adult patients with AL. The intention was to find as clinically relevant the following: symptomatic Venous Thrombosis (VT) occurred in typical (lower limbs) and atypical (cerebral, upper limbs, abdominal, etc) sites with or without pulmonary embolism (PE). Over a population of 1461 patients with AL, 22 cases of symptomatic VTE were recorded in hospitalized patients with a mean age of 54.6 years. The absolute incidence of VTE was 1.…

AdultMaleCancer Researchmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentPopulationLow molecular weight heparinHemorrhage030204 cardiovascular system & hematologyYoung Adult03 medical and health sciences0302 clinical medicineVenous thrombosisLow Molecular Weight HeparinHumansMedicineacute leukemiacardiovascular diseaseseducationAgedAged 80 and overVenous ThrombosisAcute leukemiaeducation.field_of_studyAcute leukemiaChemotherapyLeukemiabusiness.industrylow molecular weight heparinIncidenceIncidence (epidemiology)Disease ManagementVenous ThromboembolismHematologyMiddle Agedmedicine.diseasePulmonary embolismSurgeryVenous thrombosisOncology030220 oncology & carcinogenesisAcute DiseaseFemaleacute leukemia; low molecular weight heparin; Venous thrombosisbusinessSettore MED/15 - Malattie del SangueVenous thromboembolismLeukemia & Lymphoma
researchProduct

Sublingual administration of captopril in patients with acute myocardial ischemia.

1991

Summary: To investigate the anti-ischemic capability of the angiotensin-converting enzyme inhibitor captopril, 10 patients with acute myocardial ischemia (angina pectoris >1 h, ST-segment depression ±0.1 mV, no rise in creatine phosphokinase) received 25 mg captopril sublingually after being treated with an intravenous infusion of nitroglycerin (3 mg/h) and heparin (1200 IU/h) for 1 hour. A control group of 10 patients received placebo instead of captopril. Results showed a decrease of the initial ST-segment depression from 0.25±0.04 to 0.2±0.03 mV (p>0.01) with nitroglycerin for the captopril group and from 0.26±0.05 to 0.21±0.05 mV (p>0.01) for the control group. An additional decrease to…

AdultMaleCaptoprilAdministration SublingualCoronary DiseasePlaceboSublingual administrationAngina PectorisAnginaElectrocardiographyNitroglycerinHeart ratemedicineHumanscardiovascular diseasesMyocardial infarctionCreatine KinaseClinical Trials as Topicbiologybusiness.industryHemodynamicsCaptoprilGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureAnesthesiaAcute DiseaseVascular resistancebiology.proteinCreatine kinaseDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugClinical cardiology
researchProduct

Effect of acute systemic hypoxia on human cutaneous microcirculation and endothelial, sympathetic and myogenic activity

2015

The regulation of cutaneous vascular tone impacts vascular vasomotion and blood volume distribution as a challenge to hypoxia, but the regulatory mechanisms yet remain poorly understood. A skin has a very compliant circulation, an increase in skin blood flow results in large peripheral displacement of blood volume, which could be controlled by local and systemic regulatory factors. The aim of this study was to determine the acute systemic hypoxia influence on blood flow in skin, local regulatory mechanism fluctuations and changes of systemic hemodynamic parameters. Healthy subjects (n=11; 24.9±3.7years old) participated in this study and procedures were performed in siting position. After 2…

AdultMaleCardiac outputSympathetic Nervous SystemHemodynamicsBlood volumeVasomotionVasodilationBiochemistryYoung AdultHeart RateHumansMedicineCardiac OutputHypoxiaSkinbusiness.industryMicrocirculationCell BiologyBlood flowHypoxia (medical)VasodilationBlood pressureRegional Blood FlowAnesthesiaAcute DiseaseFemaleEndothelium Vascularmedicine.symptomCardiology and Cardiovascular MedicinebusinessMicrovascular Research
researchProduct

Malondialdehyde in early phase of acute pancreatitis

2011

Aims: to assess oxidative stress in acute pancreatitis, its evolution over time and its relationship with the severity of the disease. Methods: during a two-year period, patients with acute pancreatitis with less than 24 hours of pain were evaluated. Serum was obtained the first, second and fourth day from admittance, if complications were detected, and after recovery. Malondialdehyde was determined by high performance liquid chromatography. Twenty healthy volunteers constituted the control group. Malondialdehyde between groups was compared with Mann-Whitney and Kruskal-Wallis tests; malondialdehyde evolution was studied with Wilcoxon test. Results: one hundred and sixty-nine patients were …

AdultMaleComplicationsmedicine.disease_causeSeverity of Illness Indexchemistry.chemical_compoundMalondialdehydeHealthy volunteersHumansMedicineProspective StudiesChromatography High Pressure LiquidAgedAged 80 and overbusiness.industryGastroenterologyGeneral MedicineMiddle AgedPrognosismedicine.diseaseMalondialdehydeAcute pancreatitisOxidative StressPancreatitischemistryOxidative stressCase-Control StudiesAnesthesiaAcute DiseaseDisease ProgressionAcute pancreatitisPancreatitisFemalebusinessEarly phaseBiomarkersOxidative stressRevista Española de Enfermedades Digestivas
researchProduct

Strange Attractors, Chaotic Behavior and Informational Aspects of Sleep EEG Data

1992

In order to perform a nonlinear dimensional analysis of the sleep EEG, we applied an algorithm proposed to calculate the correlation dimension D2 of different sleep stages. D2 characterizes the dynamics of the sleep EEG, estimates the degrees of freedom, and describes the complexity of the signal under study. An attempt is made to correlate dimensionality analysis and informational aspects of the sleep EEG. Information processing by the brain during different sleep stages of healthy subjects under the influence of lorazepam and in unmedicated acute schizophrenics is estimated.

AdultMaleCorrelation dimensionmedia_common.quotation_subjectChaoticElectroencephalographyLorazepamInformation theoryAttractormedicineHumansElectrodesBiological Psychiatrymedia_commonSleep Stagesmedicine.diagnostic_testInformation processingElectroencephalographyPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAcute DiseaseFemaleSchizophrenic PsychologySleep StagesSleepPsychologyNeuroscienceAlgorithmsCognitive psychologyVigilance (psychology)Neuropsychobiology
researchProduct

Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population

2006

Abstract A proinflammatory genotype seems to contribute significantly to the risk of developing coronary heart disease (CHD). Conversely, the susceptibility alleles to inflammatory disease should be infrequent in the genetic background favoring longevity. In fact, in a modern environment, attainment of longevity is facilitated by an anti-inflammatory status. To evaluate whether inflammatory alleles of pyrin, the gene responsible for familial Mediterranean fever (FMF) may play an opposite role in CHD and in longevity, we examined three FMF-associated mutations, M694V (A2080G), M694I (G2082A), and V726A (T2177C), encoded by the FMF gene (MEFV) in 121 patients affected by acute myocardial infa…

AdultMaleHeterozygotemedia_common.quotation_subjectImmunologyPopulationDNA Mutational AnalysisLongevityMyocardial InfarctionMEFVFamilial Mediterranean feverEnvironmentPyrin domainProinflammatory cytokineAMIGene FrequencyRisk FactorsGenotypeImmunology and AllergyMedicineHumansProtein IsoformsGenetic Predisposition to DiseaseGenetic TestingAlleleeducationSicilyAllelesmedia_commonAged 80 and overeducation.field_of_studybusiness.industryLongevityAge FactorsCell BiologyMiddle AgedPyrinmedicine.diseaseMEFVCytoskeletal ProteinsinflammationImmunologyAcute DiseaseMutationFemalebusiness
researchProduct

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)

2006

Background In hereditary angioedema, bradykinin is assumed to be the most important mediator of edema formation. Objective To assess whether the selective bradykinin receptor-2 antagonist Icatibant is effective in acute edema attacks of hereditary angioedema. Methods In this uncontrolled pilot study, 15 patients with 20 attacks were treated with Icatibant. The attacks were analyzed by using a standardized and validated visual analog scale measurement and compared with historical data of untreated attacks. Plasma bradykinin concentration was measured before and 4 hours after intravenous Icatibant treatment. Results Symptom intensity decreased within 4 hours after administration of Icatibant;…

AdultMaleImmunologyBradykininPilot ProjectsBradykininchemistry.chemical_compoundEcallantideIcatibantBradykinin B2 Receptor AntagonistsHumansImmunology and AllergyMedicineAngioedemaBradykinin receptorBradykinin B2 Receptor AntagonistsAngioedemabusiness.industryGenetic Diseases InbornMiddle Agedmedicine.diseasechemistryAnesthesiaAcute DiseaseHereditary angioedemaFemalemedicine.symptomB2 Bradykinin Receptorbusinessmedicine.drugJournal of Allergy and Clinical Immunology
researchProduct

Determination of acetylcholine, nitrostigmine and acetylcholinesterase activity in four patients with severe nitrostigmine (E 605 forte) intoxication.

1974

Concentrations of acetylcholine and nitrostigmine as well as acetylcholinesterase activity were determined in 4 patients with severe nitrostigmine intoxication. In the acute phase of the intoxication, acetylcholine levels up to 36 and 55 ng/ml were found in blood plasma and cerebrospinal fluid, respectively. At the same time no activity of acetylcholinesterase in plasma and erythrocytes was detected. Acetylcholinesterase activity gradually recovered at the end of the second week. In the first 3 days after the ingestion plasma nitrostigmine concentrations ranged from 409 to 86 ng/ml. At the end of the third week nitrostigmine was still found in a concentration of about 1 ng/ml plasma. Redist…

AdultMaleInsecticidesErythrocytesAdolescentHealth Toxicology and MutagenesisPoison controlAdipose tissueAdministration OralPharmacologyToxicologychemistry.chemical_compoundCerebrospinal fluidOrganophosphorus CompoundsBlood plasmaMedicineIngestionHumansbusiness.industryPoisoningClinical courseGeneral MedicineMiddle AgedNitro CompoundsAcetylcholinesteraseAcetylcholineSuicidechemistryAdipose TissueIntestinal AbsorptionAcute DiseaseAcetylcholinesteraseFemalebusinessAcetylcholinemedicine.drugArchives of toxicology
researchProduct